Form 10-Q Hims & Hers Health, Inc. For: Mar 31
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/8/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Citi initiates UiPath coverage with Buy rating and $23 target
- Harry and Meghan surprised by King Charles' letter on their status
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- S&P 500 falls as AI worries hit software makers
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Hims and Hers (HIMS) PT Raised to $28 at BofA Securities
May 6, 2025 6:59 AM EDTBofA Securities analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $28.00 (from $26.00) while maintaining a Underperform rating.
The analyst comments "Following this quarters earnings, we see a wider range of outcomes for full year revenue (link to our first take here). In the first scenario, if HIMS were to grow its... More
Hims and Hers (HIMS) PT Raised to $42 at Leerink Partners
May 6, 2025 6:19 AM EDTLeerink Partners analyst Michael Cherny raised the price target on Hims and Hers (NYSE: HIMS) to $42.00 (from $40.00) while maintaining a Market Perform rating.
The analyst comments "HIMS's 2Q earnings touched on a number of key flash points as the company shifts to the next generation of GLP-1... More
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS)
May 6, 2025 4:58 AM EDTBofA Securities analyst Michael Cherny reiterated an Underperform rating and $26.00 price target on Hims and Hers (NYSE: HIMS).
The analyst comments "HIMS reported a strong quarter, with revenue of $586MM well ahead of the guidance/consensus and slightly ahead of BofAs estimate of $583.1MM. Second quarter... More
